Total Payments
$565.91
2024 Payments
$212.58
Companies
6
Transactions
23
Medicare Patients
4,197
Medicare Billing
$174,845
Payment Breakdown by Category
Food & Beverage$552.02 (97.5%)
Education$13.89 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $552.02 | 22 | 97.5% |
| Education | $13.89 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $217.15 | 8 | $0 (2017) |
| Lilly USA, LLC | $157.99 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $68.12 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $48.39 | 3 | $0 (2024) |
| Alkermes, Inc. | $48.28 | 1 | $0 (2018) |
| Biogen, Inc. | $25.98 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $212.58 | 8 | Lilly USA, LLC ($157.99) |
| 2021 | $25.98 | 1 | Biogen, Inc. ($25.98) |
| 2018 | $48.28 | 1 | Alkermes, Inc. ($48.28) |
| 2017 | $279.07 | 13 | PFIZER INC. ($217.15) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: DIABETES | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $111.54 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.76 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: DIABETES | ||||||
| 03/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Diabetes | ||||||
| 06/16/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2018 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $48.28 | General |
| Category: CNS | ||||||
| 10/20/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2017 | PFIZER INC. | VIAGRA (Drug), CHANTIX, ELIQUIS | Food and Beverage | In-kind items and services | $1.14 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 07/26/2017 | PFIZER INC. | VIAGRA (Drug), CHANTIX, ELIQUIS | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 06/20/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $98.48 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/15/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: RESPIRATORY | ||||||
| 05/31/2017 | PFIZER INC. | ELIQUIS (Drug), CHANTIX, VIAGRA | Food and Beverage | In-kind items and services | $2.23 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/10/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: RESPIRATORY | ||||||
| 05/03/2017 | PFIZER INC. | VIAGRA (Drug), CHANTIX, ELIQUIS | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 04/26/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: RESPIRATORY | ||||||
| 03/23/2017 | PFIZER INC. | CHANTIX (Drug), VIAGRA, ELIQUIS | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/07/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: RESPIRATORY | ||||||
| 02/22/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS, VIAGRA | Food and Beverage | In-kind items and services | $1.92 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/01/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $99.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,125 | 1,386 | $101,222 | $56,556 |
| 2022 | 18 | 1,012 | 1,271 | $84,974 | $45,759 |
| 2021 | 21 | 1,048 | 1,301 | $83,455 | $37,064 |
| 2020 | 21 | 1,012 | 1,213 | $85,541 | $35,466 |
Total Patients
4,197
Total Services
5,171
Medicare Billing
$174,845
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 145 | 145 | $36,250 | $18,345 | 50.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 118 | $17,818 | $10,005 | 56.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 33 | 33 | $11,532 | $9,301 | 80.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 53 | 53 | $3,975 | $3,734 | 93.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 37 | $3,720 | $2,237 | 60.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 113 | 169 | $4,901 | $2,204 | 45.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 100 | 126 | $4,536 | $2,074 | 45.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 62 | 62 | $2,294 | $1,771 | 77.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 111 | 171 | $3,933 | $1,770 | 45.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 68 | 107 | $2,247 | $1,009 | 44.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 33 | 33 | $1,221 | $973.83 | 79.8% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 94 | 126 | $1,764 | $798.84 | 45.3% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 18 | 19 | $1,653 | $768.55 | 46.5% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 26 | 41 | $2,380 | $369.34 | 15.5% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 18 | 18 | $864.00 | $340.56 | 39.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 26 | 31 | $527.00 | $235.91 | 44.8% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 31 | 35 | $420.00 | $198.10 | 47.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 31 | 35 | $350.00 | $177.80 | 50.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $616.00 | $134.88 | 21.9% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 12 | 13 | $221.00 | $107.77 | 48.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 123 | 123 | $30,750 | $15,628 | 50.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 109 | 125 | $18,875 | $10,867 | 57.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 50 | 50 | $3,750 | $3,427 | 91.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 13 | $4,225 | $2,809 | 66.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 110 | 166 | $4,814 | $2,192 | 45.5% |
About Dr. Joseph Corigliano, DO
Dr. Joseph Corigliano, DO is a Neuromusculoskeletal Medicine & OMM healthcare provider based in Lockport, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144286485.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Corigliano, DO has received a total of $565.91 in payments from pharmaceutical and medical device companies, with $212.58 received in 2024. These payments were reported across 23 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($552.02).
As a Medicare-enrolled provider, Corigliano has provided services to 4,197 Medicare beneficiaries, totaling 5,171 services with total Medicare billing of $174,845. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Neuromusculoskeletal Medicine & OMM
- Other Specialties Family Medicine
- Location Lockport, NY
- Active Since 04/25/2006
- Last Updated 01/08/2024
- Taxonomy Code 204D00000X
- Entity Type Individual
- NPI Number 1144286485
Products in Payments
- ELIQUIS (Drug) $200.17
- MOUNJARO (Drug) $157.99
- Vivitrol 380 mg (Drug) $48.28
- ADVAIR (Drug) $35.67
- JARDIANCE (Drug) $34.50
- ADUHELM (Biological) $25.98
- TRELEGY ELLIPTA (Drug) $20.09
- STIOLTO (Drug) $13.89
- BREO (Drug) $12.36
- VIAGRA (Drug) $12.18
- CHANTIX (Drug) $4.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.